rs373775451
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_152415.3(VPS37A):c.430C>A(p.Pro144Thr) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000191 in 1,613,672 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Consequence
NM_152415.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
VPS37A | NM_152415.3 | c.430C>A | p.Pro144Thr | missense_variant | 5/12 | ENST00000324849.9 | NP_689628.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
VPS37A | ENST00000324849.9 | c.430C>A | p.Pro144Thr | missense_variant | 5/12 | 1 | NM_152415.3 | ENSP00000318629.4 | ||
VPS37A | ENST00000521829.5 | c.355C>A | p.Pro119Thr | missense_variant | 4/11 | 1 | ENSP00000429680.1 | |||
VPS37A | ENST00000520140.5 | n.430C>A | non_coding_transcript_exon_variant | 5/12 | 5 | ENSP00000428823.1 | ||||
VPS37A | ENST00000425020.6 | n.488-30C>A | intron_variant | 2 | ENSP00000412824.2 |
Frequencies
GnomAD3 genomes AF: 0.000224 AC: 34AN: 152082Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000211 AC: 53AN: 251270Hom.: 0 AF XY: 0.000236 AC XY: 32AN XY: 135814
GnomAD4 exome AF: 0.000187 AC: 274AN: 1461590Hom.: 1 Cov.: 30 AF XY: 0.000186 AC XY: 135AN XY: 727132
GnomAD4 genome AF: 0.000224 AC: 34AN: 152082Hom.: 0 Cov.: 32 AF XY: 0.000256 AC XY: 19AN XY: 74290
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Feb 03, 2022 | The c.430C>A (p.P144T) alteration is located in exon 5 (coding exon 5) of the VPS37A gene. This alteration results from a C to A substitution at nucleotide position 430, causing the proline (P) at amino acid position 144 to be replaced by a threonine (T). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Hereditary spastic paraplegia 53 Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Aug 23, 2022 | In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Deleterious"; PolyPhen-2: "Benign"; Align-GVGD: "Class C0"). ClinVar contains an entry for this variant (Variation ID: 579627). This variant has not been reported in the literature in individuals affected with VPS37A-related conditions. This variant is present in population databases (rs373775451, gnomAD 0.05%). This sequence change replaces proline, which is neutral and non-polar, with threonine, which is neutral and polar, at codon 144 of the VPS37A protein (p.Pro144Thr). - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at